Case Number 3719
Request Date 22/07/2014
Completion Date 22/07/2014

 

Details of the Request

I have a request regarding prescribing for Metastatic Melanoma and Non-small cell lung carcinoma which I hope you can help me with.

1. Within your organisation how many patients are currently [last 3 months] being treated for Metastatic Melanoma [Stage IIIB/Stage IV]?

Of those patients please split by their current drug treatment;

  • Bevacizumab (Avastin)
  • Dabrafenib (Tafinlar)
  • Dacarbazine (DTIC)
  • Ipilimumab (Yervoy)
  • Trametinib (Mekinist)
  • Verumafinib (Zelboraf)
  • Other

 

2. Within your organisation how many patients are currently being treated for Non-small-cell lung carcinoma [Stage IIIB/Stage IV]?

Of those patients please split by their current drug treatment;

  • Afatinib (Giotrif)
  • Bevacizumab (Avastin)
  • Cetuximab (Erbitux)
  • Crizotinib (Xalkori)
  • Erlotinib (Tarceva)
  • Gefitinib (Iressa)
  • Pazopanib (Votrient)
  • Pemetrexed (Alimta)
  • Other

 

Details of the Response

The Trust has no patients with these two conditions. Patients requiring treatment for these conditions would receive their treatment at St Luke’s Cancer Centre in Guildford.